| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | VNLG/124 | GDSC1000 | pan-cancer | AAC | -0.039 | 0.3 |
| mRNA | thapsigargin | GDSC1000 | pan-cancer | AAC | -0.042 | 0.3 |
| mRNA | Erlotinib | CTRPv2 | pan-cancer | AAC | -0.041 | 0.3 |
| mRNA | BRD-K35604418 | CTRPv2 | pan-cancer | AAC | -0.044 | 0.3 |
| mRNA | CP724714 | GDSC1000 | pan-cancer | AAC | -0.04 | 0.3 |
| mRNA | BRD-K24690302 | CTRPv2 | pan-cancer | AAC | 0.044 | 0.3 |
| mRNA | CAY10618 | CTRPv2 | pan-cancer | AAC | -0.041 | 0.3 |
| mRNA | tipifarnib | CTRPv2 | pan-cancer | AAC | -0.037 | 0.3 |
| mRNA | Bosutinib | CTRPv2 | pan-cancer | AAC | -0.041 | 0.3 |
| mRNA | Bortezomib | GDSC1000 | pan-cancer | AAC | 0.065 | 0.3 |